A PYMNTS Company

Switzerland: Novartis limits ties to pharma rival Roche

By  |  March 2, 2014

Swiss pharmaceutical giant Novartis said Sunday it would continue to keep close ties with its rival Roche, but reportedly ruled out any merger between the two firms.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In an interview, Novartis chairman Joerg Reinhardt said the two companies “absolutely” want to remain independent of each other, but that the companies continue to communicate with each other. Novartis noted that the two firms have similar interests in similar geographical markets.

    Novartis, which owns one-third of Roche’s shares, had been rumored to be seeking a deal last October, but Roche similarly denied any such plans.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.